Cargando…
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer
Differences in the tumor immune microenvironment may result in differences in prognosis and response to treatment in cancer patients. We hypothesized that differences in the tumor immune microenvironment may exist between African American (AA) and NonAA patients, due to ancestry-related or socioecon...
Autores principales: | Marczyk, Michal, Qing, Tao, O’Meara, Tess, Yagahoobi, Vesal, Pelekanou, Vasiliki, Bai, Yalai, Reisenbichler, Emily, Cole, Kimberly S., Li, Xiaotong, Gunasekharan, Vignesh, Ibrahim, Eiman, Fanucci, Kristina, Wei, Wei, Rimm, David L., Pusztai, Lajos, Blenman, Kim R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307813/ https://www.ncbi.nlm.nih.gov/pubmed/35869114 http://dx.doi.org/10.1038/s41523-022-00449-3 |
Ejemplares similares
-
Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study
por: Yaghoobi, Vesal, et al.
Publicado: (2021) -
Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers
por: O’Meara, Tess, et al.
Publicado: (2020) -
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021) -
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2022) -
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial
por: Fanucci, Kristina A., et al.
Publicado: (2023)